2-169127752-A-ATTT
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_004525.3(LRP2):c.*910_*911insAAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0041 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
LRP2
NM_004525.3 3_prime_UTR
NM_004525.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.306
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00408 (605/148130) while in subpopulation NFE AF= 0.00752 (504/67032). AF 95% confidence interval is 0.00698. There are 0 homozygotes in gnomad4. There are 262 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRP2 | NM_004525.3 | c.*910_*911insAAA | 3_prime_UTR_variant | 79/79 | ENST00000649046.1 | ||
LRP2 | XM_011511183.4 | c.*910_*911insAAA | 3_prime_UTR_variant | 78/78 | |||
LRP2 | XM_011511184.3 | c.*910_*911insAAA | 3_prime_UTR_variant | 64/64 | |||
LRP2 | XM_047444340.1 | c.*910_*911insAAA | 3_prime_UTR_variant | 79/79 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRP2 | ENST00000649046.1 | c.*910_*911insAAA | 3_prime_UTR_variant | 79/79 | NM_004525.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00409 AC: 606AN: 148060Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
606
AN:
148060
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 368Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 228
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
368
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
228
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00408 AC: 605AN: 148130Hom.: 0 Cov.: 0 AF XY: 0.00363 AC XY: 262AN XY: 72080
GnomAD4 genome
AF:
AC:
605
AN:
148130
Hom.:
Cov.:
0
AF XY:
AC XY:
262
AN XY:
72080
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Donnai-Barrow syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at